Fluorescein as a contrasting agent for breast cancer

V. V. Lazarev; V. I. Polsachev

doi:10.1117/12.229484

8 January 1996 Fluorescein as a contrasting agent for breast cancer

V. V. Lazarev, V. I. Polsachev

Proceedings Volume 2728, CIS Selected Papers: Laser Use in Oncology; (1996) https://doi.org/10.1117/12.229484
Event: CIS Selected Papers: Laser Use in Oncology, 1995, -, Russian Federation

Abstract

The accumulation of administrated fluorescein in some breast diseases was investigated. The fluorescein concentration in about 200 macropreparations of resected mammas was measured with ratio fluorometer. The accumulation of dye in breast cancers is significantly different from that in benign diseases when determined in more than 10 hours after the dye administration. The critical value 1.75 of fluorescein accumulation factor sets the false positive error as well as false negative error to be equal to 6.6% for the fluorescent method of diagnostics. These data may be used both in express intra-surgical fluorescent diagnostics and in NMR imaging with chemically modified fluorescein.

Citation Download Citation

V. V. Lazarev and V. I. Polsachev "Fluorescein as a contrasting agent for breast cancer", Proc. SPIE 2728, CIS Selected Papers: Laser Use in Oncology, (8 January 1996); https://doi.org/10.1117/12.229484

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available